Transaction · 0001193125-26-447915

Crystal Adam

Crystal Adam, PRES, R, D, reported a transaction classified as exercise at Tango Therapeutics, Inc. involving 5000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 313090.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES, R, D
TNGXTango Therapeutics, Inc.
Trade date
Nov 02, 2026
Filing date
Nov 05, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded5.00k$0.00 per share
Holdings after313kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

TNGX price since this filing

Daily closing prices, with the filing date and available return windows
TNGX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.3%1w ago -4.2%1d ago -1.9%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001193125-26-447915
Stock Option (Right to Buy)
Transaction date
Nov 02, 2026
Filed Nov 05, 2026, 12:35 AM · 3d delay
Shares
5,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
313,090 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership 10b5-1 Detected
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, R&D

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on June 10, 2026.

  2. F2

    Represents the weighted average sales price per share. The shares sold at prices ranging from $21.83 to $22.8299 per share. Full information regarding the number of shares sold at each price shall be…

  3. F3

    Represents the weighted average sales price per share. The shares sold at prices ranging from $22.84 to $23.8399 per share. Full information regarding the number of shares sold at each price shall be…

  4. F4

    This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2026, with the remaining option shares vesting in 36 equal monthly installments thereafter.

Original filing · 0001193125-26-447915
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TNGX